ロード中...
A Comprehensive Review of US FDA-Approved Immune Checkpoint Inhibitors in Urothelial Carcinoma
Few effective treatment options are available for patients with advanced or metastatic urothelial carcinoma (UC) after unsuccessful first-line platinum-based chemotherapy. To date, immune checkpoint inhibitors are novel therapeutic agents for UC treatment. From May 2016 to May 2017, five anti-PD-1/P...
保存先:
| 出版年: | J Immunol Res |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Hindawi
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5742464/ https://ncbi.nlm.nih.gov/pubmed/29376081 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/6940546 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|